Safety of Twice Daily Sotalol in Patients with Renal Impairment: A Single Center, Retrospective Review
Journal of Atrial Fibrillation · 2018-10 · 11 (3)
DOI: 10.4022/jafib.2047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Atrial Fibrillation, online erschienen am 31.10.2018. Verfasst von Abigail Rabatin und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Ohio State University Wexner Medical Center 452 West 10th Ave Columbus, OH 43210. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Ohio State University Wexner Medical Center 452 West 10th Ave Columbus, OH 43210.
Zitieren
APA
Rabatin, A., Snider, M. J., Boyd, J. M., Houmsse, M., & Boyd, J. M. (2018). Safety of Twice Daily Sotalol in Patients with Renal Impairment: A Single Center, Retrospective Review. Journal of Atrial Fibrillation, 11(3). https://doi.org/10.4022/jafib.2047
Vancouver
Rabatin A, Snider MJ, Boyd JM, Houmsse M, Boyd JM. Safety of Twice Daily Sotalol in Patients with Renal Impairment: A Single Center, Retrospective Review. Journal of Atrial Fibrillation. 2018;11(3). doi:10.4022/jafib.2047
BibTeX
@article{Rabatin2018,
author = {Rabatin, Abigail and Snider, Melissa J and Boyd, J Michael and Houmsse, Mahmoud and Boyd, J Michael},
title = {Safety of Twice Daily Sotalol in Patients with Renal Impairment: A Single Center, Retrospective Review},
journal = {Journal of Atrial Fibrillation},
year = {2018},
volume = {11},
number = {3},
doi = {10.4022/jafib.2047}
}
EUVIMED